← All indications
HIV
Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Subtype terms (2)
More specific conditions that are subtypes of HIV in the MeSH hierarchy.
Drugs by status
Approved for this indication (1)
Phase 4 trials (115)
- rifapentine
- raltegravir
- artemether
- boceprevir
- leucovorin
- everolimus
- didanosine
- laropiprant
- meningococcal (groups A, C, Y, W) CRM197 conjugate vaccine
- icosapent ethyl
- niacin
- pneumococcal 13-valent conjugate vaccine
- ethinyl estradiol
- sofosbuvir
- rifaximin
- estradiol
- naltrexone
- calcium
- levonorgestrel
- doxycycline
- split virion influenza vaccine
- rubella virus vaccine live
- pegylated-interferon
- famotidine
- sulfadoxine
- praziquantel
- elvitegravir
- measles, mumps, and rubella vaccine
- nicotine
- hepatitis b vaccine (recombinant)
- +85 more
Phase 3 trials (46)
- high-selenium yeast
- isoniazid
- piperaquine
- procaine benzylpenicillin
- telaprevir
- vitamin d3
- mrna-1273
- dasabuvir
- tetracycline
- chloroquine
- clarithromycin
- cefixime
- metronidazole
- polio, inactivated poliovirus vaccine
- rifampin
- paritaprevir
- daclatasvir
- diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine
- ginkgo biloba
- pyrazinamide
- flucytosine
- albendazole
- bnt162b2
- dihydroartemisinin
- esomeprazole
- levofloxacin
- benzathine penicillin
- nelfinavir
- ombitasvir
- hydroxychloroquine
- +16 more
Phase 2 trials (162)
- tirzepatide
- tripterygium wilfordii
- etonogestrel
- clofazimine
- romidepsin
- pramipexole
- lp-98
- canakinumab
- vicriviroc
- ub-421
- 3bnc117
- etoricoxib
- rituximab
- pyridoxine
- thiamine
- teduglutide
- gtu-multhiv b vaccine
- Streptococcus thermophilus
- amdoxovir
- l-glutamine
- brecanavir
- topiramate
- baricitinib
- carboplatin
- bms955176
- chadox1.thivconsv1
- aramchol
- dexmedetomidine
- islatravir
- valsartan
- +132 more
Phase 1 trials (122)
- gsk3640254
- hiv-1 specific car-t cells
- dna.hti
- cd4 car+ccr5 zfn t-cells
- hydroxyethyl starch
- cd4bs
- qs-21
- mgd020
- pc-1005
- vrc-hivmab0115-00-ab
- brentuximab vedotin
- aluminum
- bleomycin
- dna-c cn54env
- l-nmma
- simvastatin
- leuprolide
- carbamazepine
- FP8v1-rTTHC
- agt103-t
- mva-cn54
- human fecal microbiota
- tmb-607
- citalopram
- enfuvirtide
- pembrolizumab
- saponin
- mosaic gp140 env trimers
- plerixafor
- calcium carbonate
- +92 more
Other trials (39)
- arginine
- levocarnitine
- fluarix
- sirtuin
- autologous microbiome
- glycolic acid
- voriconazole
- nicotinamide
- vivomixx
- maltodextrin
- bifidobacterium infantis
- lactobacillus delbrueckii
- zinc dichloride
- fumaric acid esters
- rabies vaccine (purified chick embryo cell vaccine)
- eplerenone
- zinc gluconate
- p-menthane
- prilocaine
- glucose
- lactobacillus
- peanut
- whey protein
- cidofovir
- s-adenosyl methionine
- zinc
- simeprevir
- arthrospira platensis
- fluorouracil
- 18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose
- +9 more